✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Hester Biosciences Ltd.

HESTERBIO

Market Cap
₹1,900 Cr.
P/E
34.14

Hester Biosciences Ltd.

  • Hester Biosciences
  • NGL Fine-Chem
  • Solara Active Pharma
  • TJI Pharma - Small Cap

FAQs on Hester Biosciences Ltd. Shareprice

Hester Biosciences has given lower returns compared to its competitors.
Hester Biosciences has grown at ~2.94% over the last 7yrs while peers have grown at a median rate of 25.26%

Hester Biosciences is not expensive.
Latest PE of Hester Biosciences is 34.14, while 3 year average PE is 56.78.
Also latest EV/EBITDA of Hester Biosciences is 24.02 while 3yr average is 32.59.

View FAQ's On Business

Growth Table

  • Hester Biosciences Ltd.
  • NGL Fine-Chem
  • Solara Active Pharma

Balance Sheet

  • Hester Biosciences Ltd.
  • NGL Fine-Chem
  • Solara Active Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Hester Biosciences Ltd.
  • NGL Fine-Chem
  • Solara Active Pharma

Cash Flow

  • Hester Biosciences Ltd.
  • NGL Fine-Chem
  • Solara Active Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Hester Biosciences Ltd.
  • NGL Fine-Chem
  • Solara Active Pharma

Quarterly Results

  • Hester Biosciences Ltd.
  • NGL Fine-Chem
  • Solara Active Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Hester Biosciences Ltd. Financials

Balance sheet of Hester Biosciences is strong.
But short term working capital might become an issue for this company.

The net debt of Hester Biosciences is decreasing.
Latest net debt of Hester Biosciences is ₹176 Crs as of Mar-26.
This is less than Mar-25 when it was ₹194 Crs.

Yes, profit is increasing.
The profit of Hester Biosciences is ₹55.64 Crs for Mar 2026, ₹27.49 Crs for Mar 2025 and ₹18.89 Crs for Mar 2024

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Hester Biosciences latest dividend payout ratio is 16.82% and 3yr average dividend payout ratio is 21.83%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech